Regulatory science plays a critical role in addressing regulatory risks by developing new tools, standards, and approaches to assess the safety, efficacy, and quality of medical products. Advances in [biomarkers](), [real-world evidence](), and [personalized medicine]() are examples of how regulatory science can help mitigate risks and facilitate the approval of innovative cancer treatments.
